Richard Cirillo, MD
Orthopaedic Surgery · Prince Frederick, MDNPI 1144379173
Payments from drug & device makers
What this record shows
This record is dominated by education: $909 of the $1,499 with a category attached, or 60.6%. Supreme Orthopedic Systems, LLC accounts for 63.3% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $921 and has fallen 82.4% since, to $162 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in MD, where the typical reported total is $2,738.
Across 27 payments — averaging $55.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supreme Orthopedic Systems, LLC$950
- Pacira Pharmaceuticals Incorporated$88
- Stryker$73
- Biocomposites Inc$41
- Pacira Therapeutics, Inc.$41
- Smith+Nephew$40
- plus $267 from 11 others
What the payments were for
- Food & beverage$59139%
- Education$90961%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supreme Orthopedic Systems, LLC | 3 | $950 |
| Pacira Pharmaceuticals Incorporated | 4 | $88 |
| Stryker(2 entities) | 3 | $73 |
| Biocomposites Inc | 1 | $41 |
| Pacira Therapeutics, Inc. | 2 | $41 |
| Smith+Nephew | 2 | $40 |
| Fidia Pharma USA Inc. | 2 | $39 |
| Polymedics Innovations Inc. | 1 | $37 |
| KCI USA, Inc. | 1 | $27 |
| Heron Therapeutics, Inc. | 1 | $27 |
| Johnson & Johnson | 1 | $27 |
| Organogenesis Inc. | 1 | $22 |
| Sanara Medtech Inc. | 1 | $21 |
| Convatec Inc. | 1 | $19 |
| Vertex | 1 | $19 |
| Acumed LLC | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $12 |
How this compares
$1,499 in reported general payments places this provider in the 35th percentile of 378 orthopaedic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 107 | $1,868 |
| Naproxen | 26 | $850 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 111 | $602 |
| Methylprednisolone | 52 | $370 |
| Cyclobenzaprine Hcl | 50 | $356 |
| Gabapentin | 35 | $313 |
| Ibuprofen | 37 | $310 |
| Meloxicam | 60 | $252 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $108 |
| Tramadol Hcl | 31 | $50 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Prince Frederick
- Mark MyersonBaltimore$10.5M
- David DaluryTowson$7.6M
- Anand MurthiBaltimore$3.7M
- Timothy CoddTowson$3.6M
- Khaled KebaishBaltimore$3M
- Michael AinLutherville$1.6M
- Shawn StandardBaltimore$1.4M
- Hamid HassanzadehBethesda$1.1M
- Paul SponsellerBaltimore$958K
- Paul TortolaniTowson$812K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.